Status:
RECRUITING
Secretin in Refeeding
Lead Sponsor:
University of California, Los Angeles
Conditions:
Anorexia in Adolescence
Eligibility:
All Genders
13-24 years
Brief Summary
Patients with restrictive-type anorexia nervosa who are admitted to the hospital for feeding often urinate excessive amounts. Others have changes in the way that they handle acid and base. These issue...
Eligibility Criteria
Inclusion
- Group 1:
- male and female patients
- age 13-24 years
- diagnosis of restrictive-type anorexia nervosa
- hospitalization for nutritional support
- \>4 cc/kg/day of urine output (a.k.a. "fluid dumpers"; n=5)
- Group 2:
- male and female patients
- age 13-24 years
- diagnosis of restrictive-type anorexia nervosa
- hospitalization for nutritional support
- \<2 cc/kg/d of urine output (a.k.a. "non-dumpers"; n=5)
Exclusion
- 5150 hold
- Anti-depressant, anti-psychotic, or anticonvulsant medications
- Previous hospitalization within the past 6 months
- Underlying metabolic disorder not related to anorexia nervosa (including chronic kidney disease, renal tubular disorders, and underlying endocrine disorders)
- Pregnancy
- NG or G-tube feeds after day 2 of hospitalization
- \> 10% of nutritional needs from supplemental feeds
Key Trial Info
Start Date :
February 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05235867
Start Date
February 1 2022
End Date
December 31 2024
Last Update
March 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Los Angeles (UCLA)
Los Angeles, California, United States, 90095